ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

2 Day Virtual Training Course: Managing Service Providers including CRO (Contract Research Organisation) and CMOs Oversight to Comply with ICH GCP (Good Clinical Practice) R3 (Oct 16th-17th, 2025) - ResearchAndMarkets.com

The "Managing Service Providers including CRO (Contract Research Organisation) and CMOs oversight to comply with ICH GCP (Good Clinical Practice) R3 Training Course (Oct 16th - Oct 17th, 2025)" training has been added to ResearchAndMarkets.com's offering.

This course will also help CRO/vendor personnel to work more successfully with pharmaceutical, biotechnology and medical device companies through gaining a much clearer understanding of their needs when outsourcing.

With regulatory inspectors increasingly finding issues with vendor oversight by sponsor organisations, it is becoming even more important for the pharmaceutical industry to employ efficient and accurate strategies for managing outsourced activities. A company's ability to identify and select the right CRO/ vendor for the right project and manage them efficiently and effectively will help to ensure compliance with the regulator's expectations.

On this course you will learn how to prepare a request for proposal (RFP), evaluate and select the right CRO and establish procedures for vendor oversight for R&D projects you need to outsource. You will also cover the techniques for successfully managing CROs/ vendors and the shared responsibilities required by the sponsor and the service provider. Managing CRO performance issues will also be discussed.

The course is equally useful to CROs/other vendors and consultants to understand how to work effectively with sponsor organisations.

Who Should Attend:

This event is designed for personnel involved in CRO/vendor management and oversight in the pharmaceutical, biotechnology, animal health and medical device industries including those working in clinical research, regulatory affairs, pharmacovigilance, manufacturing, clinical outsourcing, contracts, quality, clinical operations, vendor management and global QA/compliance. It will also be relevant for outsourcing, purchasing, finance and contract management staff who participate in the RFP process who will find this course a valuable introduction or refresher course focusing on best practice.

Benefits of attending

  • Understand how to effectively manage CROs/vendors used in the pharma industry
  • Build an understanding of your responsibilities as the sponsor and identify the right level of management and oversight
  • Discuss how to put in place a robust CRO/vendor selection process
  • Discover tools and processes to manage CROs and other vendors
  • Measure CRO performance including metrics and key performance indicators (KPIs)

Certifications:

  • CPD: 12 hours for your records
  • Certificate of completion

Key Topics Covered:

Day 1

Background to the CRO industry and meeting regulatory expectations

  • Outsourcing today for the biopharma industry
  • Different models of outsourcing
  • Challenges of working with CROs/Vendors and solutions
  • Core components of Vendor Governance
  • The potential benefits and drivers of outsourcing
  • Outsourcing Trends

Oversight of CROS/Vendors and meeting regulatory inspectors' expectations

  • Understanding Oversight
  • Key elements of Vendor Oversight
  • Examples of Vendor Oversight documents
  • Examine EU and FDA expectations for outsourcing in the pharma and biopharma industry

Building an effective relationship

  • Factors critical for a successful relationship
  • Building trust

Vendor/CRO selection - an overview of selection and bidding processes

  • Identifying Vendors/ CROs
  • Preparing the RFP
  • Evaluating responses to the RFP
  • Pre-qualification of vendors and vendor audits
  • Writing the RFP
  • Contracts with Vendors/CROs
  • Bid defence meetings

Day 2

Vendor/CRO selection - an overview of selection and bidding processes - continued

Managing vendor/CRO project set-up

  • How to set the stage so the CRO focuses on quality
  • Effective Kick-off meetings
  • Training CROs
  • Which SOPs should CROs use?
  • Risk assessment
  • Tools and techniques for managing CRO performance
  • Understand the KPIs/ dashboards
  • Communications with CROs

Ongoing oversight and management

  • Tracking and measuring CRO progress and performance
  • Ongoing training and integrating new CRO staff
  • Maintaining effective communication with your CRO
  • Report processes to manage CROs/vendors
  • Progress and update meetings/TCs with CROs
  • Meetings with CROs
  • Update reports
  • Auditing CROs
  • Escalation
  • Troubleshooting problems with CROs - common problems and possible solutions

End of project oversight: reviewing CROs during and at the end of the project

  • Review meetings
  • Feedback and learnings for using in the future
  • Evaluation of suppliers

For more information about this training visit https://www.researchandmarkets.com/r/ahirjm

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Recent Quotes

View More
Symbol Price Change (%)
AMZN  247.94
+3.53 (1.44%)
AAPL  269.23
+0.76 (0.28%)
AMD  244.43
+10.89 (4.66%)
BAC  53.80
+0.60 (1.13%)
GOOG  288.45
+8.75 (3.13%)
META  633.82
+12.11 (1.95%)
MSFT  502.77
+5.95 (1.20%)
NVDA  196.48
+8.33 (4.43%)
ORCL  242.01
+2.75 (1.15%)
TSLA  447.23
+17.71 (4.12%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.